Manufacturers Life Insurance Company, The Adagio Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	N/A	-122,964 Closed	0 $0
Q1 2023 May 15, 2023	SELL	N/A	-100,404 Reduced 81.65%	22,560 $74,000
Q4 2022 Aug 11, 2023	BUY	$3.08 - $4.05 $34,249 - $45,036	11,120 Added 9.94%	122,964 $407,000
Q4 2022 Feb 13, 2023	BUY	$3.08 - $4.05 $34,249 - $45,036	11,120 Added 9.94%	122,964 $407,000
Q3 2022 Aug 11, 2023	BUY	$2.97 - $4.83 $27,808 - $45,223	9,363 Added 9.14%	111,844 $350,000
Q3 2022 Nov 03, 2022	BUY	$2.97 - $4.83 $27,808 - $45,223	9,363 Added 9.14%	111,844 $340,000
Q2 2022 Aug 11, 2023	BUY	$2.54 - $4.52 $80,769 - $143,731	31,799 Added 44.99%	102,481 $336,000
Q2 2022 Aug 15, 2022	BUY	$2.54 - $4.52 $80,769 - $143,731	31,799 Added 44.99%	102,481 $338,000
Q1 2022 Aug 11, 2023	BUY	$3.81 - $10.77 $183,344 - $518,273	48,122 Added 213.31%	70,682 $322,000
Q1 2022 May 20, 2022	BUY	$3.81 - $10.77 $220,637 - $623,690	57,910 Added 453.41%	70,682 $343,000
Q4 2021 Feb 16, 2022	BUY	$6.35 - $47.04 $6,623 - $49,062	1,043 Added 8.89%	12,772 $99,000
Q3 2021 Nov 12, 2021	BUY	$20.88 - $56.08 $244,901 - $657,762	11,729 New	11,729 $495,000

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.